Page last updated: 2024-09-04

ampelopsin and Diabetes Mellitus, Adult-Onset

ampelopsin has been researched along with Diabetes Mellitus, Adult-Onset in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (60.00)24.3611
2020's4 (40.00)2.80

Authors

AuthorsStudies
Cai, G; Hou, L; Hu, CY; Huang, B; Jiang, F; Jiang, Y; Liu, D; Wang, C; Zheng, W1
Liu, Q; Liu, S; Peng, Q; Wang, J; Zhang, Y1
Chen, N; Feng, SD; Li, MW; Li, Q; Ling, HY; Luo, JD; Wang, ZH; Wu, HL1
Feng, S; He, J; Li, Q; Ling, H; Song, Z; Wang, Z; Yan, C; Yang, S1
Gao, Y; Ge, H; Guan, S; Hao, Y; He, L; Huang, R; Liu, L; Shen, Y; Sun, M; Xiong, W; Yin, C1
Feng, S; He, J; Liao, D; Ling, H; Wu, D; Yang, J; Yang, S; Zhu, Z1
Feng, SD; He, JQ; Ling, HY; Yang, JH; Yang, SS; Zhang, KF; Zhu, ZM1
Fan, L; Fang, J; Gong, Y; Lin, T; Shi, C; Wang, W; Yin, M; Zhao, X; Zhou, X1
Chen, M; Hu, Q; Huang, J; Liang, X; Mi, M; Shi, L; Zhang, Q; Zhang, T; Zhou, Y; Zhu, J1
Lang, H; Liu, L; Mi, M; Si, M; Wan, J; Zhou, Y; Zhu, J1

Other Studies

10 other study(ies) available for ampelopsin and Diabetes Mellitus, Adult-Onset

ArticleYear
Dihydromyricetin Ameliorates Inflammation-Induced Insulin Resistance via Phospholipase C-CaMKK-AMPK Signal Pathway.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: AMP-Activated Protein Kinases; Animals; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Diabetes Mellitus, Type 2; Flavonols; Inflammation; Insulin Resistance; Male; Mice, Inbred C57BL; Signal Transduction

2021
[Dihydromyricetin improves cardiac insufficiency by inhibiting HMGB1 in diabetic rats].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022, May-20, Volume: 42, Issue:5

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Heart Failure; HMGB1 Protein; Male; Metformin; NF-kappa B; Rats; Rats, Sprague-Dawley

2022
[Dihydromyricetin improves Parkinson's disease-like lesions in T2DM rats by activating AMPK/ULK1 pathway].
    Sheng li xue bao : [Acta physiologica Sinica], 2023, Feb-25, Volume: 75, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Autophagy-Related Protein-1 Homolog; Diabetes Mellitus, Type 2; Parkinson Disease; Rats; Rats, Sprague-Dawley

2023
Dihydromyricetin alleviates hippocampal ferroptosis in type 2 diabetic cognitive impairment rats via inhibiting the JNK-inflammatory factor pathway.
    Neuroscience letters, 2023, 08-24, Volume: 812

    Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Ferroptosis; Hippocampus; Iron; Rats

2023
Dihydromyricetin affects BDNF levels in the nervous system in rats with comorbid diabetic neuropathic pain and depression.
    Scientific reports, 2019, 10-10, Volume: 9, Issue:1

    Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Comorbidity; Depression; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Flavonols; Hippocampus; Humans; Male; Pain Measurement; Rats; Receptor, trkB; Signal Transduction; Streptozocin

2019
Dihydromyricetin improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain-derived neurotrophic factor-mediated neuroprotection in mice.
    Acta biochimica et biophysica Sinica, 2018, Mar-01, Volume: 50, Issue:3

    Topics: Ampelopsis; Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Maze Learning; Mice; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Phytotherapy; Plant Extracts

2018
[The effects of dihydromyricetin on cognitive dysfunction in type 2 diabetes mice].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2017, Apr-08, Volume: 33, Issue:4

    Topics: Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Hippocampus; Learning; Memory; Mice; Mice, Inbred C57BL

2017
Preparation of a nanoscale dihydromyricetin-phospholipid complex to improve the bioavailability: in vitro and in vivo evaluations.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019, Oct-01, Volume: 138

    Topics: Animals; Biological Availability; Calorimetry, Differential Scanning; Diabetes Mellitus, Type 2; Flavonols; Male; Microscopy, Electron, Scanning; Particle Size; Phospholipids; Rats; Rats, Sprague-Dawley; Solubility; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2019
Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway.
    Molecular and cellular endocrinology, 2015, Jul-05, Volume: 409

    Topics: Adenine; AMP-Activated Protein Kinases; Animals; Autophagy; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavonols; Gene Expression Regulation; Insulin Resistance; Macrolides; Male; Muscle, Skeletal; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction

2015
Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats.
    Molecular and cellular endocrinology, 2017, 01-05, Volume: 439

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Flavonols; Hyperglycemia; Insulin Resistance; Male; Obesity; Rats; Rats, Zucker; Time Factors; Weight Gain

2017